SMITHKLINE BEECHAM: New era in type 2 diabetes management.

0 Comments | M2 Presswire, June, 1999

M2 PRESSWIRE-25 June 1999-SMITHKLINE BEECHAM: New era in type 2 diabetes management (C)1994-99 M2 COMMUNICATIONS LTD RDATE:230699 * Avandia only TZD indicated for initial monotherapy and in combination with Metformin * Avandia Shows Promising Results When Used In Combination With Other Diabetes Therapies According To Data Presented At The American Diabetes Association Annual Meeting SAN DIEGO, CA -- Avandia (rosiglitazone maleate, SmithKline Beecham) improves blood sugar control in combination with other diabetes medications, according to studies presented at the annual scientific sessions of the American Diabetes Association (ADA).

These studies showed that Avandia -- a new insulin-sensitizer recently approved by the FDA as monotherapy or in...